IMiDs induce hematopoietic malignancies
The mechanism for the previously unknown occurrence of thrombocytopenia and neutropenia in patients with myeloma treated with immunomodulatory drugs (IMiDs) has finally been understood from clinical t...
Author: VJHemOnc
Added: 09/28/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts